Abstract
In 2020 COVID-19 led to an unprecedented stream of papers being submitted to journals. Scientists and physicians all around the globe were in need for information about this new disease. In this climate, many articles were accepted after extremely fast peer-reviews to provide the scientific community with the latest discoveries and knowledge. Unfortunately, this also led to articles retraction due to authors’ misconduct or errors in methodology and/or conclusions. The aim of this study is to investigate the number and characteristics of retracted papers, and to explore the main causes that led to retraction. We conducted a systematic review on retracted articles, using PubMed as data source. Our inclusion criteria were the following: English-language retracted articles that reported original data, results, opinions or hypotheses on COVID-19 and Sars-CoV-2. Twenty-seven retracted articles were identified, mainly reporting observational studies and opinion pieces. Many articles published during the first year of the pandemic have been retracted, mainly due to the authors' scientific misconduct. Duplications, plagiarism, frauds and absence of consent, were the main reasons for retractions. In modern medicine, researchers are required to publish frequently, and, especially during situations like the COVID-19 pandemic, when articles were rapidly published, gaps in peer-reviews system and in the path to scientific publication arose.
Keywords: Retracted, Frauds, COVID-19, Peer-review, Systematic review, Misconduct
Introduction
In present times, the creation of sound scientific evidence in healthcare lies within the Evidence-Based Medicine (EBM) framework; scholars trust their peers to review their work, and, if it is found to be rigorous and unbiased, the process ends with publication (Boetto et al. 2020). The COVID-19 pandemic had a significant effect on scientific literature and practice in underlining their greatest strengths by promoting interprofessional collaborations and sharing ideas between multiple sites (Hynicka et al. 2022; Pawłowicz-Szlarska et al. 2022; Lincoln et al. 2022). These vivid collaborations sparked by the pandemic outbreak, united with globalization and easy online access, led to an enormous stream of research papers: to understand the scale of this phenomenon, Dimension Database estimates well over 870,000 research papers published about COVID-19, from 198 countries, in 2020 and 2021 alone, as compared to 109,000 papers regarding Seasonal Influenza published between 2015 and 2019 (Dimension Database 2022). In 2020 a great deal -around 33%- of academic papers about COVID-19 were disseminated as pre-prints, which could be published online without the need for peer review (Franser et al. 2021; Watson 2022), and this contributed to the infodemic which altered mass media information (Palayew et al. 2020; Pian et al. 2021; Corinti et al. 2022). These preprints were eventually screened by peers, but the vast amount of information needing peer-review led to decreased review times for COVID-19 papers, mainly at the expense of other topics (Else 2020).
The overwhelming need for quick peer-reviews, combined with the necessity for focused healthcare workers, made the peer-review and publication process more vulnerable to errors, and amplified the risk of lacking transparency and reproducibility in studies, and therefore of frauds and misconducts (Publications Office of the EU 2020). Publishing timeframes have also become increasingly tight during the pandemic, due to expedited review and fast-tracks specifically suited for COVID-19 papers (Bagdasarian et al. 2020; Benjamens et al. 2021; Schonhaut et al. 2022). As a result, as Yeo-Teh and al. described in their work (Yeo-Teh et al. 2019), the retraction rate spiked to alarming heights, having more than tripled from a pre-pandemic retraction rate regarding viruses and epidemics of 0.021% to a COVID-19 related retraction rate of 0.074%. This worrying pattern is reaffirmed in comparing present times retraction rates with past ones, as retractions were most commonly related to either Basic Life Sciences or Technology, rather than medicine, and, furthermore, the number of retractions per journal did not change since 1756–2019 (Vuong et al. 2020).
In this scenario, a noteworthy number of authors acted mistakenly or sometimes even maliciously to exploit this “opportunity” by submitting papers of dubious scientific value, duplicating their submission to various journals, plagiarizing others’ work, or plainly tampering data to fit their assumption. On the other hand, other authors simply made honest mistakes or suffered from unreliable data; at this date Retraction Watch has listed 253 COVID-19 related, retracted, papers (Retraction Watch 2022). Although peer review is designed to promptly assess methodology and conclusion flaws, it is not yet fully equipped to deal rapidly with shady behaviors, especially during times of high demand of information, such as the COVID-19 pandemic. All the aforementioned issues had serious consequences, reducing trust in science and medicine, fueling misinformation and contributing to the infodemic.
Aim of the study
We reviewed the COVID-19 related scientific literature to investigate the number and characteristics of retracted papers, and to explore the main causes or motivations that led to retraction.
Methods
Search strategy and selection criteria
We conducted a systematic review of the scientific literature, following the Preferred Reporting Items for Systematic Reviews (PRISMA) approach (Moher et al. 2009), to identify COVID-19-related quantitative and qualitative studies of different designs published during the pandemic and then retracted for any cause.
The initial search was implemented on March 1, 2022 and was limited to the timespan between December 1, 2019 and December 31, 2021. The search query consisted of terms considered pertinent by the authors to review the literature on retracted COVID-19 articles. We searched for publications on Pubmed using the following search string: “(retracted publication[pt]) AND ((covid*) OR (coronavirus) OR (Sars-c*))”. We included English-language retracted articles that reported original data, results, opinions or hypotheses on COVID-19 and Sars-CoV-2. We excluded studies that did not focus on COVID-19 as the primary subject of the study or considered it as a background factor only.
Data extraction
Data was extracted by four independent reviewers (AC, AS, FS, DGor), and disagreement on extracted data was discussed with one independent tiebreaker (DGol). Descriptive variables extracted from each article and journal were: publishing journal, journal’s 3-year impact factor, first author affiliation’s country (categorized in high-income, middle-high income, middle-low-income and low-income countries (The World Bank 2021)), study type, data availability, analyzed population, sample size, aim, results, retraction statement, who first requested retraction, subscription or open access, funding and timestamps of publication and retraction (i.e., time between date of publication and date of retraction). Articles’ lifespan and the time difference between the timestamps were extracted from the article information or full-text. Whenever the exact day was not provided and the article reported only the month, we referred to the 15th of the same month as the corresponding date.
The following categories were assigned to retraction statements: Process, Misconduct and Others. Each of these categories had specific reasons for retraction, “Process” included: “Approval issue”, which implied problems regarding the use of data, “Error”, which implied problems regarding the methodology of the study and “Not reproducible”, which implied the non-reproducibility of the study due to inaccessible data. “Misconduct” comprehended all mischievous behaviors by authors: fraud, plagiarism and duplication of the article. Finally, the label “Other” was used to categorize all those retraction statements which did not fall in the previous labels, in this category we found two specific reasons: “not first-hand account”, “premature conclusions”, “redundant”, “out of journal scope”, “publisher error” and “not specified”.
Results
Of the initial 69 records identified, 66 full-text articles matched our inclusion criteria and were assessed and included in the review (Fig. 1, Table 1). 38 studies were published in 2020 and 28 in 2021. Studies' characteristics are summarized in Table 1. Although we did not limit our search to specific study types, the majority of retracted articles were either observational studies (n = 34, 52%) or opinion papers (n = 11, 17%) (Fig. 2 and Table 1), followed by reviews articles (n = 9, 14%), experimental (n = 7, 11%), meta-analysis (n = 4, 6%), study protocol (n = 1, 1%). Three studies were excluded during the screening process (Zellmer 2021; Hill et al. 2021a, b; Liu et al. 2020) since COVID-19 was not the main focus of the paper. The included studies came from all regions of the world, with 46 (60%) of the articles drafted in high-income countries (Table 1).
Fig. 1.
PRISMA flowchart
Table 1.
Included articles’ summary
Title | Country | Journal | 3-year IF | Study type | Retraction label | Specific reasons for retraction | OA article | Retraction requested/accepted by authors | Journal type | Δt retraction (days) |
---|---|---|---|---|---|---|---|---|---|---|
Racial disparity amongst stroke patients during the coronavirus disease 2019 pandemic | USA | Cureus | 0.00 | Observational | Process | Approval issue | Yes | No | Open | 125 |
Effects of the covid-19 pandemic on stroke patients | USA | Cureus | 0.00 | Observational | Process | Approval issue | Yes | No | Open | 142 |
Noteworthy neurological manifestations associated with covid-19 infection | USA | Cureus | 0.00 | Observational | Misconduct | Fraud | Yes | No | Open | 245 |
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection mimicking as pulmonary tuberculosis in an inmate | USA | Cureus | 0.00 | Observational | Process | Error | Yes | Yes | Open | 452 |
Severe dengue with multisystem inflammatory syndrome in children due to COVID-19: A Co-infection case series | Bangladesh | Cureus | 0.00 | Observational | Process | Error | Yes | No | Open | 4 |
Smoker, former smoker and COVID-19: nicotine does not protect against SARS-CoV-2 | Spain | Arch Bronconeumol | 0.69 | Observational | Other | NS | Yes | No | Subscription/open | 4 |
Covid-19, suicide, and femicide: rapid research using google search phrases | New Zealand | J Gen Psychol | 0.75 | Review | Process | Error | No | Yes | Subscription/open | 117 |
Basic demographic parameters help predict outcomes in patients hospitalized With COVID-19 during the first wave of infection in West Texas | USA | J Prim Care Community Health | 0.96 | Observational | Process | Approval issue | Yes | Yes | Open | 256 |
A retrospective analysis and comparison of prisoners and community-based patients with COVID-19 requiring intensive care during the first phase of the pandemic in West Texas | USA | J Prim Care Community Health | 0.96 | Observational | Process | Approval issue | Yes | Yes | Open | 321 |
Clinical characteristics and blood test results in covid-19 patients | China | Ann Clin Lab Sci | 1.02 | Observational | Process | Error | No | Yes | Subscription | 61 |
Retracted: facemasks in the covid-19 era: a health hypothesis | USA | Med Hypotheses | 1.46 | Review | Other | Premature Conclusions | No | No | Subscription/open | 171 |
Retracted: 5 g technology and induction of coronavirus in skin cells | Italy | J Biol Regul Homeost Agents | 1.47 | Opinion | Misconduct | Fraud | No | No | Subscription | 37 |
Retracted: A study of potential SARS-CoV-2 antiviral drugs and preliminary research of their molecular mechanism, based on Anti-SARS-CoV drug screening and molecular dynamics simulation | China | J Comput Biol | 1.48 | Experimental | Other | Premature conclusions | Yes | Yes | Subscription/open | 226 |
WITHDRAWN: health risk assessment and health management of urban residents facing epidemic pneumonia | China | Work | 1.51 | Observational | Misconduct | Fraud | Yes | No | Subscription/open | 107 |
Convalescent plasma therapy in covid 19: every dark cloud has a silver lining | India | J Anaesthesiol Clin Pharmacol | 1.74 | Opinion | Misconduct | Duplication | Yes | No | Subscription/open | 94 |
Noninvasive versus invasive ventilation: one modality cannot fit all during covid-19 outbreak | India | Korean J Anesthesiol | 1.79 | Review | Misconduct | Plagiarism | Yes | No | Open | 68 |
Efficacy and safety of acupuncture therapy for asymptomatic infection of covid-19: a protocol for systematic review and meta-analysis | China | Medicine (Baltimore) | 1.87 | Study protocol | Misconduct | Duplication | Yes | No | Open | 161 |
Human immunodeficiency virus (HIV) and outcomes from coronavirus disease 2019 (COVID-19) pneumonia: A Meta-Analysis and Meta-Regression | Indonesia | AIDS res hum retroviruses | 1.91 | Meta-analysis | Misconduct | Plagiarism | No | No | Subscription/open | 125 |
Withdrawn: a mechanistic analysis placental intravascular thrombus formation in covid-19 patients | USA | Ann diagn pathol | 1.92 | In vitro | Misconduct | Duplication | Yes | No | Subscription/open | 58 |
Impact of the COVID-19 pandemic on stroke epidemiology and clinical stroke practice in the US | USA | J Stroke cerebrovasc dis | 1.95 | Observational | Process | Approval Issue | Yes | No | Subscription/open | 165 |
Mental health burden for the public affected by the covid-19 outbreak in china: who will be the high-risk group? | China | Psychol health med | 2.00 | Observational | Misconduct | Duplication | Yes | No | Subscription/open | 192 |
Vitritis and outer retinal abnormalities in a patient with COVID-19 | Brazil | Ocul immunol inflamm | 2.02 | Observational | Process | Error | No | No | Subscription/open | 366 |
Implementation of a telemedicine service during COVID-19 pandemic in Pakistan | Pakistan | Int J Clin Pract | 2.04 | Experimental | Process | Error | Yes | Yes | Subscription/open | 147 |
Clinical characteristics and outcomes of patients with COVID-19 pneumonia admitted to an intensive care unit in Faisalabad, Pakistan | Pakistan | Int J Clin Pract | 2.04 | Observational | Misconduct | Fraud | Yes | Yes | Subscription/open | 201 |
Neutrophil/lymphocyte ratio-A marker of COVID-19 pneumonia severity | Pakistan | Int J Clin Pract | 2.04 | Observational | Misconduct | Fraud | Yes | Yes | Subscription/open | 401 |
Obesity and mortality of covid-19. Meta-analysis | UK | Obes Res Clin Pract | 2.17 | Meta-analysis | Process | Error | Yes | Yes | Subscription/open | 212 |
COVID-19 admissions calculators – revisited | Malta | Early Hum Dev | 2.18 | Observational | Other | Premature conclusions | Yes | Yes | Subscription/open | 424 |
COVID-19 admissions calculators: general population and paediatric cohort | Malta | Early Hum Dev | 2.18 | Observational | Other | Premature conclusions | Yes | Yes | Subscription/open | 433 |
Unknown unknowns—COVID-19 and potential global mortality | Malta | Early Hum Dev | 2.18 | Observational | Other | Premature conclusions | Yes | Yes | Subscription/open | 437 |
Clinical sequelae of the novel coronavirus: does covid-19 infection predispose patients to cancer? | USA | Future Oncol | 2.22 | Review | Misconduct | Plagiarism | Yes | No | Subscription/open | 189 |
RETRACTED: Biopsychosocial intersections of social/affective touch and psychiatry: Implications of 'touch hunger' during COVID-19 | India | Int J Soc Psychiatry | 2.24 | Review | Misconduct | Fraud | Yes | No | Subscription/open | 275 |
A deep learning model and machine learning methods for the classification of potential coronavirus treatments on a single human cell | Egypt | J Nanopart Res | 2.25 | Observational | Other | Out of journal scope | Yes | No | Subscription/open | 303 |
Coronavirus disease-2019: a brief compilation of facts | India | J Oral Maxillofac Pathol | 2.27 | Opinion | Misconduct | Plagiarism | Yes | No | Subscription/open | 53 |
Efficacy of favipiravir in COVID-19 treatment: a multi-center randomized study | Egypt | Arch Virol | 2.44 | Experimental | Process | Error | Yes | No | Subscription/open | 301 |
Anal swab as a potentially optimal specimen for sars-cov-2 detection to evaluate hospital discharge of covid-19 patients | China | Future Microbiol | 2.51 | Observational | Misconduct | Absence of consent by patients | Yes | No | Subscription/open | 242 |
Clinical and scientific rationale for the "MATH + " hospital treatment protocol for COVID-19 | USA | J Intensive Care Med | 2.51 | Review | Process | Error | Yes | No | Subscription/open | 329 |
Chinese mental health burden during the covid-19 pandemic | China | Asian J Psychiatr | 2.53 | Observational | Misconduct | Duplication | Yes | No | Subscription/open | 217 |
Covid-19 and potential global mortality – revisited | Malta | Early Hum Dev | 2.53 | Opinion | Other | Premature Conclusions | Yes | Yes | Subscription/open | 330 |
The mechanisms of action of ivermectin against SARS-CoV-2-an extensive review | Italy | J Antibiot (Tokyo) | 2.69 | Review | Process | Error | Yes | No | Subscription/open | 104 |
SARS-CoV-2 vaccination and antibody testing in immunosuppressed populations: you can't tell the players without a scorecard [RETRACTED] | USA | Transplantation | 2.83 | Opinion | Misconduct | Duplication | Yes | No | Subscription/open | 63 |
Meta-analysis of randomized trials of ivermectin to treat SARS-CoV-2 infection | UK | Open Forum Infect Dis | 3.02 | Meta-analysis | Process | Error | Yes | Yes | Open | 214 |
Methylene blue photochemical treatment as a reliable SARS-CoV-2 plasma virus inactivation method for blood safety and convalescent plasma therapy for COVID-19 | China | BMC Infect Dis | 3.02 | Experimental | Process | Error | Yes | No | Open | 86 |
Lung ultrasound score in establishing the timing of intubation in covid-19 interstitial pneumonia: a preliminary retrospective observational study | China | PLoS One | 3.21 | Observational | Misconduct | Duplication | Yes | No | Open | 119 |
Tracking COVID-19 vaccine hesitancy and logistical challenges: a machine learning approach | Canada | PLoS One | 3.21 | Observational | Process | Approval Issue | Yes | Yes | Open | 50 |
Identify and measure the degree of over-prevention behaviors in the post-COVID-19 era in China | China | BMC Public Health | 3.36 | Observational | Misconduct | Fraud | Yes | No | Open | 76 |
Comment on an article: "Osteoporosis in the age of COVID-19 patients" | Bosnia and Herzegovina | Osteoporos Int | 3.59 | Opinion | Other | Redundant | Yes | No | Subscription/open | 174 |
A meta-analysis of granulocyte–macrophage colony-stimulating factor (GM-CSF) antibody treatment for COVID-19 patients | China | Ther Adv Chronic Dis | 4.42 | Meta-analysis | Process | Error | Yes | No | Open | 93 |
Retracted: The safety of COVID-19 vaccinations-we should rethink the policy | Poland | Vaccines | 4.42 | Observational | Process | Error | Yes | No | Open | 8 |
Phytotherapeutic options for the treatment of covid-19: a concise viewpoint | Pakistan | Phytother Res | 4.55 | Opinion | Misconduct | Plagiarism | Yes | Yes | Subscription/open | 132 |
Safety and efficacy of favipiravir versus hydroxychloroquine in management of COVID-19: A randomised controlled trial | Egypt | Sci Rep | 4.60 | Experimental | Misconduct | Fraud | No | No | Subscription/open | 171 |
Exploring the potential effect of COVID-19 on an endangered great ape | Denmark | Sci Rep | 4.60 | Observational | Process | Error | Yes | Yes | Subscription/open | 96 |
GraphCovidNet: A graph neural network based model for detecting COVID-19 from CT scans and X-rays of chest | India | Sci Rep | 4.60 | Observational | Process | Error | Yes | No | Subscription/open | 229 |
Stay-at-home policy is a case of exception fallacy: an internet-based ecological study | Brazil | Sci Rep | 4.60 | Observational | Process | Error | Yes | No | Subscription/open | 284 |
Retracted: no deleterious effect of lockdown due to covid-19 pandemic on glycaemic control, measured by glucose monitoring, in adults with type 1 diabetes | Spain | Diabetes Technol Ther | 4.80 | Observational | Process | Approval issue | Yes | No | Subscription/open | 76 |
Effects of a single dose of ivermectin on viral and clinical outcomes in asymptomatic SARS-CoV-2 infected subjects: a pilot clinical trial in Lebanon | Lebanon | Viruses | 5.02 | Experimental | Process | Error | Yes | Yes | Open | 153 |
Rationale and criteria for a COVID-19 model framework | Italy | Viruses | 5.02 | Review | Misconduct | Plagiarism | Yes | No | Open | 23 |
Intersectionality and inequalities in medical risk for severe COVID-19 in the Canadian longitudinal study on aging | Canada | Gerontologist | 5.27 | Observational | Process | Approval issue | Yes | Yes | Subscription/open | 120 |
Analyzing pre-pandemic patterns of contacts is partly inappropriate to explain the current COVID-19 situation in Germany | Germany | Lancet Reg Health Eur | 6.37 | Review | Other | Publisher error | Yes | No | Open | 28 |
Retracted article: sars-cov-2 infects t lymphocytes through its spike protein-mediated membrane fusion | China | Cell Mol Immunol | 6.76 | In vitro | Process | Error | Yes | Yes | Subscription/open | 94 |
Will the extraction of COVID-19 from wastewater help flatten the curve? | South Africa | Chemosphere | 7.18 | Observational | Misconduct | Duplication | Yes | No | Subscription/open | 231 |
Effectiveness of surgical and cotton masks in blocking sars-cov-2: a controlled comparison in 4 patients | South Korea | Ann Intern Med | 9.79 | Opinion | Process | Error | Yes | No | Subscription/open | 57 |
Chinese medical staff request international medical assistance in fighting against covid-19 | China | Lancet Glob Health | 22.28 | Opinion | Other | Not first hand account | Yes | No | Subscription/open | 3 |
Family planning in COVID-19 times: access for all | Kenya | Lancet Glob Health | 22.28 | Opinion | Process | Error | Yes | Yes | Subscription/open | 38 |
Cardiovascular disease, drug therapy, and mortality in covid-19 | USA | N Engl J Med | 40.27 | Observational | Process | Not reproducible | Yes | No | Subscription/open | 34 |
Chloroquine or hydroxychloroquine for covid-19: why might they be hazardous? | France | Lancet | 47.90 | Opinion | Process | Not reproducible | Yes | Yes | Subscription/open | 48 |
Retracted: hydroxychloroquine or chloroquine with or without a macrolide for treatment of covid-19: a multinational registry analysis | USA | Lancet | 47.90 | Observational | Process | Not reproducible | Yes | No | Subscription/open | 14 |
Fig. 2.
Number of publications by study type
The most frequent label attributed to the articles’ retraction was “process” (32, 48%), followed by “misconduct” (23, 35%). As for retraction’s specific reasons, “Authors’ Error” (21, 32%), “Approval Issue” (8, 12%), “Fraud” (8, 12%) and “Duplication” (8, 12%) were the most frequent ones (Fig. 3). The articles’ retraction followed authors’ self-report in 35% (23) of the included records. Most of the retracted articles (45, 68%) were submitted to hybrid journals, whereas 19 (29%) were submitted to open-access journals and 2 (3%) to subscription-only journals. Interestingly, 91% (60) of the included articles were published with the open access model. The median journals’ impact factor was 2.352 (Range: 0—47.9).
Fig. 3.
Number of publications by retraction’s specific reason
The median number of days that occurred between publication and retraction was 137 (Range: 3—452). This timespan differed among retractions’ specific reasons: articles with the “premature conclusions” label were the ones retracted after the longest period, with a mean of 337 days. The fastest retraction occurred for the study labeled as “Not first hand account” (3 days). As for study type, the 34 meta-Observational studies were those with the longest mean lifespan by study type (mean = 191). On the other hand, the 11 opinion papers were the ones with the shorter timespan (mean = 94 days) (Fig. 4).
Fig. 4.
Time to retraction by A study type and B retraction’s specific reason
For reference, the entirety of the selected papers can be found in Table 1, and their citations are as follows: Ghanchi et al. 2020a, b; Elkhouly et al. 2020; An et al. 2020; Mulvey et al. 2020; Huang et al. 2021; Sun et al. 2020; Huang et al. 2020; Lu et al. 2020; Beato-Víbora 2020; Mehra et al. 2020a, b; Mehra et al. 2020a, b; Walach et al. 2021; Dutta et al. 2021; Friedlich et al. 2021; Ali et al. 2020a, b; Lin 2021; Ali et al. 2020a, b; Khalifa et al. 2020; Gul et al. 2021; Victor 2020a, b; Victor 2020a, b; Colchero et al. 2021; Saha et al. 2021; Ma et al. 2021; Imran et al. 2021; Akbar et al. 2020; Ferdous et al. 2021; Jiménez-Ruiz et al. 2021; Savaris et al. 2021; Grech 2020a, b; Zago Filho et al. 2020; Atangana et al. 2021; Mao et al. 2021; Fioranelli et al. 2020; Deokar et al. 2020; Temmerman 2021; Ibrahimagić et al. 2021; Saxena 2020; Grech 2020a, b; Din et al. 2020; Bae et al. 2020; Zeng et al. 2020; Funck-Brentano et al. 2020; Woodle et al. 2021; Standish 2021; Vainshelboim 2021; Singh 2020; Hays 2020; Kampf 2022; Kory et al. 2021; Messina et al. 2021; Banerjee et al. 2021; Zaidi et al. 2022; Wang et al. 2020; Jin et al. 2021; Zhao et al. 2020; Samaha et al. 2021; Dabbous et al. 2021; Nagra et al. 2021; Dabbous et al. 2021; Hussain et al. 2020; Hariyanto et al. 2019; Hill et al. 2021a, b; Guan et al. 2021; Huang et al. 2020.
Discussion
In this systematic literature review, we sought and described the characteristics of the COVID-19 related retracted papers that were accepted in impacted journals after the peer review process during the first two years of the COVID-19 pandemic (2020–2021).
We found that observational studies were the most retracted ones, followed by opinion papers and reviews; this could be a consequence of the epidemic outbreak, since in a brief period of time it was not possible to properly design and publish results from Randomized Controlled Trials (RCTs) or methodologically sound prospective studies, while observational retrospective studies can be set up and conducted more rapidly, being, nonetheless, at higher risk of several types of bias and pitfalls (Viswanathan et al. 2013; Grimes et al. 2002).
We found misconduct and process-related issues as the most prominent cause of paper retraction. As an example of observational study that got retracted due to misconduct reasons, Sun M, et al. (Sun et al. 2020), in their article “Anal swab as a potentially optimal specimen for SARS-CoV-2 detection to evaluate hospital discharge of COVID-19 patients” did not acquire patients’ consent prior to publication in order to conduct their study. Even though these issues have always been there for the scientific path to publication, a stress test such as COVID-19 amplified their detrimental effects.
An interesting peer-review process’ pitfall can be described recalling one attempt at meta-analysis by Hussain et Al. (Hussain et al. 2020). The retraction statement goes: “This article has been retracted at the request of the authors due to inadvertent errors (such as in the calculation of odds ratio for age and naming patients’ groups in the plots) that unfortunately passed unnoticed during the extremely rapid review and publication process at the peak of the COVID-19 pandemic”. This meta-analysis wanted to assess how mortality by COVID-19 was influenced by obesity, and it was based on data from the first four months of the pandemic. This retracted study demonstrates the importance of relying on sound scientific methods and rigorous peer-reviews. Furthermore, one study supported the non-effectiveness of both surgical and cotton masks in preventing the dissemination of SARS-CoV-2 from patients with COVID-19 (Bae et al. 2020). It is possible that this type of publications can have a negative indirect effect on health policy decisions and therefore on the health of the population.
Notably, Impact-Factor (IF) was extremely heterogeneous, and some articles found their way to high IF journals, as was the case with the two articles published in the New England Journal of Medicine and The Lancet, by Dr. Mandeep R. Mehra et Al., who utilized an unfit database taking part in the “Surgisphere Scandal” (Baker et al. 2020). Articles published in high IF journals were checked and retracted relatively quickly, while articles published in journals with lower IFs took much more time to be community checked and retracted. A possible explanation for this is that journals with higher IF have more visibility and are therefore read by a higher number of experts. As a result, poor quality articles are more easily spotted and forced to retraction. Overall, journals’ IF was found to be relatively high and with high variance. This means IF cannot always be considered as a guarantee for peer-review quality, as various authors have stated in their work (Vrabel 2019; Paulus et al. 2018; Juyal et al. 2019).
As for retracted papers’ geographic distribution, we found that the Asian continent was the most afflicted. This represents a direct consequence of one key factor: the urgent need for information within the epicenter of the pandemic, which required observational studies to be preferred during the first months of the pandemic, even though these are more easily tampered in their data and afflicted with errors in their method (Viswanathan et al. 2013; Grimes et al. 2002).
In order to address these issues, publishers, editors and other stakeholders should focus on several aspects of the path to scientific publication: improving the process by granting adequate peer-review times (Barnabic et al. 2022; COVID-19 Report 2022; Improving pandemic preparedness and management 2020); using open data when possible or making it always available upon reasonable requests (Hynicka et al. 2022). It could also be beneficial to use distributed ledger technologies (eg, blockchains) in order to tamper proof data and its analysis or machine learning to double check data (Boetto et al. 2020).
Study limitations
This review presents various limitations. First, we may have missed other studies since we used only one database. Secondly, information about specific reasons for article retraction are only available in the article retraction statement, therefore the comprehensiveness of retraction motivations could not be as complete as it should.
Although these limitations exist, to the best of our knowledge no other studies on the subject have been published yet. This study therefore starts a much-needed discussion on the topic of peer reviewed scientific literature during times in which the need for accurate new information is in high demand. Finally, in reading this review, a healthy dose of discretion is advised, since we do not suggest the academic situation was much better or worse before the pandemic, but only analyze the effects COVID-19 has had on the scientific path to publication.
Conclusions
In a modern scientific community in which “publish or perish” is still mandatory and h-index is considered a sound metric to value scholars, quantity is frequently prioritized over quality. Although peer-reviewers usually defend the scientific community's integrity, the publication process is not perfect and it can miss its target, as reported here about the COVID-19 pandemic. Open access and fast track paths to publication are useful tools but might represent a menace if left unchecked since the former can be an incentive to accept manuscripts, and the latter can lead to lower quality threshold and reduced attention by peer-reviewers.
It is reasonable to assume the retracted articles found in this review are just the tip of an iceberg of dubious-value publications pre- and during the pandemic. During times of great stress, such as the SARS-CoV-2 pandemic, this should be considered a menace for the integrity of modern science as well as for the well-being of the global community since unchecked facts and fake evidence are the ground on which fake news thrive.
Author contributions
AC had the idea, contributed to data extraction and to drafting the manuscript; AS contributed to data extraction and to drafting the manuscript; FS data extraction and analyzed the data; DG contributed to data extraction and to drafting the manuscript; DG contributed to drafting the manuscript and coordinated the project. All authors read and approved the final manuscript.
Funding
The authors declare that no funds, grants, or other support were received during the preparation of this manuscript.
Declarations
Competing interests
The authors have no relevant financial or non-financial interests to disclose. The views expressed in this article are those of the authors and do not necessarily reflect the position or policy of the Italian or the United States government, nor of the institutions the authors are affiliated with.
Footnotes
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
References
- Akbar, H., Kahloon, R., Akbar, S., Kahloon, A.; Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection mimicking as pulmonary tuberculosis in an inmate. Cureus. 12(6):e8464 (2020). doi: 10.7759/cureus.8464. Retraction in: Cureus. 2021 Aug 31;13(8):r34 [DOI] [PMC free article] [PubMed]
- Ali, K., Rao, S., Dennis, J., Berdine, G., Test, V., Nugent, K.: Basic demographic parameters help predict outcomes in patients hospitalized with covid-19 during the first wave of infection in West Texas. J Prim Care Community Health. 11:2150132720970717 (2020a). doi: 10.1177/2150132720970717. Retraction in: J Prim Care Community Health. 2021 Jan-Dec;12:21501327211033367 [DOI] [PMC free article] [PubMed] [Retracted]
- Ali, K., Rao, S., Berdine, G, Test, V., Nugent, K.: A retrospective analysis and comparison of prisoners and community-based patients with COVID-19 requiring intensive care during the first phase of the pandemic in West Texas. J. Prim. Care Community Health. 11:2150132720954687 (2020b). doi: 10.1177/2150132720954687. Retraction in: J Prim Care Community Health. 2021 Jan-Dec;12:21501327211033367 [DOI] [PMC free article] [PubMed] [Retracted]
- An, X.S., Li, X.Y., Shang, F.T., Yang, S.F., Zhao, J.Y., Yang, X.Z., Wang, H.G.: Clinical characteristics and blood test results in COVID-19 patients. Ann. Clin. Lab. Sci.;50(3):299–307 (2020). Retraction in: Ann Clin Lab Sci. 2020 Jul;50(4):560 [PubMed]
- Atangana, E., Oberholster, P.J., Turton, A.R.: Will the extraction of COVID-19 from wastewater help flatten the curve? Chemosphere. 271:129429 (2021). doi: 10.1016/j.chemosphere.2020.129429. Epub 2021 Jan 5. Retraction in: Chemosphere. 2021 Nov;283:131992 [DOI] [PMC free article] [PubMed]
- Bae, S., Kim, M.C., Kim, J.Y., Cha, H.H., Lim, J.S., Jung, J., Kim, M.J., Oh, D.K., Lee, M.K., Choi, S.H., Sung, M., Hong, S.B., Chung, J.W., Kim, S.H.: Effectiveness of surgical and cotton masks in blocking SARS-CoV-2: a controlled comparison in 4 patients. Ann. Intern. Med. 173(1):W22-W23 (2020). doi: 10.7326/M20-1342. Epub 2020 Apr 6. Retraction in: Ann Intern Med. 2020 Jun 2 [DOI] [PMC free article] [PubMed] [Retracted]
- Bagdasarian N, Cross GB, Fisher D. Rapid publications risk the integrity of science in the era of COVID-19. BMC Med. 2020;18(1):192. doi: 10.1186/s12916-020-01650-6.PMID:32586327;PMCID:PMC7315694. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Baker N, Van Noorden R, Maxmen A. Coronapod: the surgisphere scandal that rocked coronavirus drug research. Nature. 2020 doi: 10.1038/d41586-020-01790-y. [DOI] [PubMed] [Google Scholar]
- Banerjee, D., Vasquez, V., Pecchio, M., Hegde, M.L., Ks, Jagannatha, R., Rao, T.S.: RETRACTED: Biopsychosocial intersections of social/affective touch and psychiatry: Implications of 'touch hunger' during COVID-19. Int J Soc Psychiatry. 20764021997485 (2021). doi: 10.1177/0020764021997485. Epub ahead of print. Retraction in: Int J Soc Psychiatry. 2021 Nov 26;:207640211063062 [DOI] [PubMed]
- Barnabic C, Rambob I, Berman BM, et al. Interprofessional culinary medicine training enhanced nutrition knowledge, nutrition counseling confidence, and interprofessional experience. J. Integr. Complement. Med. 2022 doi: 10.1089/jicm.2022.0573. [DOI] [PubMed] [Google Scholar]
- Beato-Víbora, P.I., RETRACTED: No deleterious effect of lockdown due to COVID-19 pandemic on glycaemic control, measured by glucose monitoring, in adults with type 1 diabetes. Diabetes Technol Ther. (2020) doi: 10.1089/dia.2020.0184. Epub ahead of print. Retraction in: Diabetes Technol. Ther. 2020 Aug;22(8):643. PMID: 32396400. [DOI] [PubMed]
- Benjamens S, Pol RA, de Meijer VE, et al. Peer review during demanding times: maintain rigorous standards. Scientometrics. 2021 doi: 10.1007/s11192-021-04007-9. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Boetto, E., Golinelli, D., Carullo, G., et al. Frauds in scientific research and how to possibly overcome them. J. Med. Eth. Published Online First: 06 October 2020. 10.1136/medethics-2020-106639 [DOI] [PubMed]
- Colchero, F., Eckardt, W., Stoinski, T.: Exploring the potential effect of COVID-19 on an endangered great ape. Sci. Rep. 11(1):20715 (2021). doi: 10.1038/s41598-021-00061-8. Retraction in: Sci Rep. 2022 Jan 25;12(1):1624 [DOI] [PMC free article] [PubMed] [Retracted]
- Corinti F, Pontillo D, Giansanti D. COVID-19 and the infodemic: an overview of the role and impact of social media, the evolution of medical knowledge, and emerging problems. Healthc. (basel). 2022 doi: 10.3390/healthcare10040732. [DOI] [PMC free article] [PubMed] [Google Scholar]
- COVID-19 Report: publications, clinical trials, funding - data obtained on August 9, 2022, from Digital Science’s Dimensions platform, https://covid-19.dimensions.ai
- Dabbous, H.M., Abd-Elsalam, S., El-Sayed, M.H., Sherief, A.F., Ebeid, F.F.S., El Ghafar, M.S.A., Soliman, S., Elbahnasawy, M., Badawi, R., Tageldin, M.A.: Efficacy of favipiravir in COVID-19 treatment: a multi-center randomized study. Arch Virol. 166(3):949–954. (2021). doi: 10.1007/s00705-021-04956-9. Epub 2021 Jan 25. Retraction in: Arch Virol. 2022 Jan;167(1):277 [DOI] [PMC free article] [PubMed] [Retracted]
- Dabbous, H.M., El-Sayed, M.H., El Assal, G., Elghazaly, H., Ebeid, F.F.S., Sherief, A.F., Elgaafary, M., Fawzy, E., Hassany, S.M., Riad, A.R., TagelDin, M.A.: Safety and efficacy of favipiravir versus hydroxychloroquine in management of COVID-19: A randomised controlled trial. Sci. Rep. 11(1):7282 (2021). doi: 10.1038/s41598-021-85227-0. Retraction in: Sci Rep. 2021 Sep 18;11(1):18983 [DOI] [PMC free article] [PubMed]
- Deokar, K., Chawla, G., Shadrach, B.J., Dutt, N.: Convalescent plasma therapy in COVID 19: every dark cloud has a silver lining. J. Anaesthesiol Clin. Pharmacol. 36(3):419–423 (2020). doi: 10.4103/joacp.JOACP_523_20. Epub 2020 Oct 16. Retraction in: J Anaesthesiol Clin Pharmacol. 2020 Oct-Dec;36(4):573 [DOI] [PMC free article] [PubMed] [Retracted]
- Din, M., Ali, F., Waris, A., Zia, F., Ali, M.: Phytotherapeutic options for the treatment of COVID-19: A concise viewpoint. Phytother Res. 34(10):2431–2437 (2020). doi: 10.1002/ptr.6786. Epub 2020 Aug 20. Retraction in: Phytother Res. 2021 Jan;35(1):542 [DOI] [PMC free article] [PubMed]
- Dutta, S., Kumar, A., Dutta, M., Walsh, C.: Tracking COVID-19 vaccine hesitancy and logistical challenges: a machine learning approach. PLoS One. 2021 Jun 2;16(6):e0252332. doi: 10.1371/journal.pone.0252332. Retraction in: PLoS One. 2021 Jul 22;16(7):e0255347 [DOI] [PMC free article] [PubMed] [Retracted]
- Elkhouly, A., Kaplan, A.C.: Noteworthy neurological manifestations associated with COVID-19 infection. Cureus.;12(7):e8992 (2020). doi: 10.7759/cureus.8992. Retraction in: Cureus. 5 Mar 2021;13(3):r26 [DOI] [PMC free article] [PubMed] [Retracted]
- Else H. How a torrent of COVID science changed research publishing - in seven charts. Nature. 2020;588(7839):553. doi: 10.1038/d41586-020-03564-y. [DOI] [PubMed] [Google Scholar]
- Ferdous, A., Hossain, M.M., Afrin, M.: Severe dengue with multisystem inflammatory syndrome in children due to COVID-19: a co-infection case series. Cureus. 13(11):e19516 (2021). doi: 10.7759/cureus.19516. Retraction in: Cureus. 2021 Nov 16;13(11):r35 [DOI] [PMC free article] [PubMed] [Retracted]
- Fioranelli, M., Sepehri, A., Roccia, M.G., Jafferany, M., Olisova, O.Y., Lomonosov, K.M., Lotti, T.: RETRACTED: 5G Technology and induction of coronavirus in skin cells. J Biol Regul Homeost Agents. (2020). 10.23812/20-269-E-4. doi: 10.23812/20-269-E-4. Epub ahead of print. Retraction in: J Biol Regul Homeost Agents. 2020 Jul 16;34(4) [DOI] [PubMed]
- Fraser N, Brierley L, Dey G, et al. The evolving role of preprints in the dissemination of COVID-19 research and their impact on the science communication landscape. PLoS Biol. 2021;19(4):e3000959. doi: 10.1371/journal.pbio.3000959. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Friedlich, D., Newman, T., Bricker, S.: Impact of the COVID-19 pandemic on stroke epidemiology and clinical stroke practice in the US. J Stroke Cerebrovasc Dis. 30(4):105639 (2021). doi: 10.1016/j.jstrokecerebrovasdis.2021.105639. Epub 2021 Jan 26. Retraction in: J Stroke Cerebrovasc Dis. 2021 Aug;30(8):105982 [DOI] [PMC free article] [PubMed] [Retracted]
- Funck-Brentano, C., Salem, J.E.: Chloroquine or hydroxychloroquine for COVID-19: why might they be hazardous? Lancet. S0140–6736(20)31174–0 (2020). doi: 10.1016/S0140-6736(20)31174-0. Epub ahead of print. Retraction in: Lancet. 2020 Jul 18;396(10245):e2-e3 [DOI] [PMC free article] [PubMed]
- Ghanchi, H., Takayanagi, A., Savla, P., Hariri, O.R., Tayag, E.C., Schiraldi, M., Jorgensen, L., Miulli DE.: Effects of the COVID-19 pandemic on stroke patients. Cureus.;12(8):e9995 (2020a). doi: 10.7759/cureus.9995. Retraction in: Cureus. 2021 Jan 13;13(1):r22 [DOI] [PMC free article] [PubMed]
- Ghanchi, H., Patchana, T., Wiginton, J., 4th, Browne, J.D., Ohno, A., Farahmandian, R., Duong, J., Cortez DE Miulli, V.: Racial disparity amongst stroke patients during the coronavirus disease 2019 pandemic Cureus. 12 9 e10369 (2020b). 10.7759/cureus.10369. Retraction in: Cureus. 2021 Jan 13;13(1):r21 [DOI] [PMC free article] [PubMed]
- Grech, V.: Unknown unknowns - COVID-19 and potential global mortality. Early Hum Dev. 144:105026 (2020a). doi: 10.1016/j.earlhumdev.2020.105026 Retraction in: Early Hum Dev. 2021 Aug;159:105377 [DOI] [PMC free article] [PubMed]
- Grech, V.: COVID-19 and potential global mortality - Revisited. Early Hum Dev. 144:105054 (2020b). doi: 10.1016/j.earlhumdev.2020b105054. Epub 2020b Apr 30. Retraction in: Early Hum Dev. 2021 Mar 26;156:105341 [DOI] [PMC free article] [PubMed]
- Grimes DA, Schulz KF. Bias and causal associations in observational research. Lancet. 2002;359(9302):248–252. doi: 10.1016/S0140-6736(02)07451-2. [DOI] [PubMed] [Google Scholar]
- Guan, J.T., Wang, W.J., Jin, D., Mou, X.Y., Lei, S.S., Xu, Z.H.: A meta-analysis of granulocyte-macrophage colony-stimulating factor (GM-CSF) antibody treatment for COVID-19 patients. Ther Adv Chronic Dis. 12:20406223211039699 (2021). doi: 10.1177/20406223211039699. Retraction in: Ther Adv Chronic Dis. 2021 Nov 21;12:20406223211056430 [DOI] [PMC free article] [PubMed] [Retracted]
- Gul, N., Usman, U., Ahmed, U., Ali, M., Shaukat, A., Imran, M.M.: Clinical characteristics and outcomes of patients with COVID-19 pneumonia admitted to an intensive care unit in Faisalabad, Pakistan. Int. J. Clin. Pract. 75(6):e14152 (2021). doi: 10.1111/ijcp.14152. Epub 2021 Mar 25. Retraction in: Int. J. Clin. Pract. 2021 Dec;75(12):e14926 [DOI] [PMC free article] [PubMed] [Retracted]
- Hariyanto, T.I., Putri, C., Frinka, P., Louisa, J., Lugito, N.P.H., Kurniawan, A.: Human immunodeficiency virus (HIV) and outcomes from coronavirus disease 2019 (COVID-19) pneumonia: a meta-analysis and meta-regression. AIDS Res Hum Retroviruses. (2021). 10.1089/AID.2020.0307. Epub ahead of print. Retraction in: AIDS Res Hum Retroviruses. 2021 Jun;37(6):503 [DOI] [PubMed]
- Hays, P.: Clinical sequelae of the novel coronavirus: does COVID-19 infection predispose patients to cancer? Future Oncol. 16(20):1463–1474 (2020). doi: 10.2217/fon-2020-0300. Epub 2020 May 27. Retraction in: Future Oncol. 2020 Dec;16(35):3015 [DOI] [PubMed]
- Hill, A., Garratt, A., Levi, J., Falconer, J., Ellis, L., McCann, K., Pilkington, V., Qavi, A., Wang, J., Wentzel, H.: Meta-analysis of Randomized Trials of Ivermectin to Treat SARS-CoV-2 Infection. Open Forum Infect Dis. 8(11):ofab358 (2021a). doi: 10.1093/ofid/ofab358. Retraction in: Open Forum Infect Dis. 2022 Feb 05;9(3):ofac056 [DOI] [PMC free article] [PubMed] [Retracted]
- Hill, A., Garratt, A., Levi, J., Falconer, J., Ellis, L., McCann, K., Pilkington, V., Qavi, A., Wang, J., Wentzel, H.: Erratum: expression of concern: "meta-analysis of randomized trials of ivermectin to treat SARS-CoV-2 Infection". Open Forum Infect Dis. 8(8):ofab394 (2021b). doi: 10.1093/ofid/ofab394 [DOI] [PMC free article] [PubMed] [Retracted]
- Huang, Y., Zhao, N.: Chinese mental health burden during the COVID-19 pandemic. Asian J Psychiatr. 51:102052 (2020). doi: 10.1016/j.ajp.2020.102052. Epub 2020 Apr 14. Retraction in: Asian J Psychiatr. 2020 Dec;54:102482 [DOI] [PMC free article] [PubMed]
- Huang, Y., Zhao, N.: Mental health burden for the public affected by the COVID-19 outbreak in China: Who will be the high-risk group?. Psychol. Health. Med.;26(1):23–34 (2021). doi:10.1080/13548506.2020.1754438. Epub 2020 Apr 14. Retraction in: Psychol Health Med. 2020 Oct 23;:1 [DOI] [PubMed]
- Huang, S., Wang, S., Li, G., Wang, M., Yu, W., Shao, G., Zhang, J., Yang, D.: Efficacy and safety of acupuncture therapy for asymptomatic infection of COVID-19: A protocol for systematic review and meta-analysis. Medicine (Baltimore). 99(41):e22697 (2020). doi: 10.1097/MD.0000000000022697. Retraction in: Medicine (Baltimore). 2021 Mar 19;100(11):e25227 [DOI] [PMC free article] [PubMed] [Retracted]
- Hussain, A., Mahawar, K., Xia, Z., Yang, W., El-Hasani, S.: Obesity and mortality of COVID-19. Meta-analysis. Obes. Res. Clin. Pract. 14(4):295–300 (2020). doi: 10.1016/j.orcp.2020.07.002. Epub 2020 Jul 9. Retraction in: Obes Res Clin Pract. 2021 Jan-Feb;15(1):100. [DOI] [PMC free article] [PubMed]
- Hynicka, L.M., Piedrahita, G., Barnabic, C., Rambob, I., Berman, B.M., D'Adamo, C.R. Interprofessional culinary medicine training enhanced nutrition knowledge, nutrition counseling confidence, and interprofessional experience. J Integr Complement Med. 28(10):811–820 (2022). 10.1089/jicm.2022.0573 [DOI] [PubMed]
- Ibrahimagić, O.Ć., Vujadinović, A., Ercegović, Z., Kunić, S., Smajlović, D., Dostović, Z.: Comment on an article: "Osteoporosis in the age of COVID-19 patients". Osteoporos Int. 32(4):783–784 (2021). doi: 10.1007/s00198-020-05607-6. Epub 2021 Jan 21. Retraction in: Osteoporos Int. 2021 Jul 14 [DOI] [PMC free article] [PubMed] [Retracted]
- Improving pandemic preparedness and management - publications office of the eu - group of chief scientific advisors to the European commission, European Group on Ethics in Science and New Technologies (EGE), Special advisor to President Ursula von der Leyen on the response to the coronavirus and COVID-19 – (2020).
- Imran, M.M., Ahmad, U., Usman, U., Ali, M., Shaukat, A., Gul, N.: Neutrophil/lymphocyte ratio-A marker of COVID-19 pneumonia severity. Int. J. Clin. Pract. 75(4):e13698 (2021). doi: 10.1111/ijcp.13698. Epub 2021 Jan 12. Retraction in: Int J Clin Pract. 2021 Dec;75(12):e14927 [DOI] [PubMed]
- Jiménez-Ruiz, C.A., López-Padilla, D., Alonso-Arroyo, A., Aleixandre-Benavent, R., Solano-Reina, S., de Granda-Orive, J.I.: Smoker, former smoker and COVID-19: nicotine does not protect against SARS-CoV-2. Arch Bronconeumol (Engl Ed). 2021 Mar 16. doi: 10.1016/j.arbr.2021.03.012 [DOI] [PMC free article] [PubMed]
- Jin, C., Yu, B., Zhang, J., Wu, H., Zhou, X., Yao, H., Liu, F., Lu, X., Cheng, L., Jiang, M., Wu, N.: Methylene blue photochemical treatment as a reliable SARS-CoV-2 plasma virus inactivation method for blood safety and convalescent plasma therapy for COVID-19. BMC Infect Dis. 21(1):357 (2021). doi: 10.1186/s12879-021-05993-0. Retraction in: BMC Infect Dis. 2021 Jul 9;21(1):672 [DOI] [PMC free article] [PubMed] [Retracted]
- Juyal, D., Thawani, V., Sayana, A., Pal, S.: Impact factor: mutation, manipulation, and distortion. J Family Med Prim Care. 15;8(11):3475-3479 (2019). doi: 10.4103/jfmpc.jfmpc_515_19 [DOI] [PMC free article] [PubMed]
- Kampf, G.: Analyzing pre-pandemic patterns of contacts is partly inappropriate to explain the current COVID-19 situation in Germany. Lancet Reg Health Eur. 12:100290 (2022). doi: 10.1016/j.lanepe.2021.100290. Epub 2021 Dec 13. Retraction in: Lancet Reg Health Eur. 2022 Jan;12:100298. Erratum in: Lancet Reg Health Eur. 2022 Jan;12:100298. [DOI] [PMC free article] [PubMed] [Retracted]
- Khalifa, N.E.M., Taha, M.H.N., Manogaran, G., Loey, M.: A deep learning model and machine learning methods for the classification of potential coronavirus treatments on a single human cell. J. Nanopart. Res.;22(11):313 (2020). doi: 10.1007/s11051-020-05041-z. Epub 2020 Oct 17. Retraction in: J Nanopart Res. 2021;23(8):184 [DOI] [PMC free article] [PubMed] [Retracted]
- Kory, P., Meduri, G.U., Iglesias, J., Varon, J., Marik, P.E.: Clinical and scientific rationale for the "MATH+" hospital treatment protocol for COVID-19. J. Intensive Care Med. 36(2):135–156 (2021). doi: 10.1177/0885066620973585. Epub 2020 Dec 15. Retraction in: J Intensive Care Med. 2021 Nov 9;:8850666211049062. [DOI] [PubMed]
- Lin, S.L.: Intersectionality and inequalities in medical risk for severe COVID-19 in the Canadian Longitudinal study on aging. Gerontologist. 13;61(5):e245 (2021). doi: 10.1093/geront/gnaa143. Retraction in: Gerontologist. 2021 Jul 13;61(5):e244 [DOI] [PMC free article] [PubMed]
- Lincoln M, Gabr A, Kennedy C, et al. Collaboration, supervision and patient safety in the era of COVID-19: an analysis of medical wards and ICU. Ir. J. Med. Sci. 2022;191(3):1085–1087. doi: 10.1007/s11845-021-02693-1. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Liu, Y., Jiang, T.T., Shi, T.Y., Liu, Y.N., Liu, X.M., Xu, G.J., Li, F.L., Wang, Y.L., Wu, X.Y.: WITHDRAWN: The effectiveness of diaphragmatic breathing relaxation training for improving sleep quality among nursing staff during the COVID-19 outbreak: a before and after study. Sleep Med X. 2:100026 (2020). doi: 10.1016/j.sleepx.2020.100026. Retraction in: Sleep Med X. 2020 Dec;2:100030 [DOI] [PMC free article] [PubMed] [Retracted]
- Lu, X., Zhang, M., Qian, A., Tang, L., Xu, S.: Lung ultrasound score in establishing the timing of intubation in COVID-19 interstitial pneumonia: a preliminary retrospective observational study. PLoS One. 3;15(9):e0238679 (2020). doi: 10.1371/journal.pone.0238679. Retraction in: PLoS One. 2020 Dec 31;15(12):e0245032 [DOI] [PMC free article] [PubMed] [Retracted]
- Ma, R., Wu, H., Deng, Z.: Identify and measure the degree of over-prevention behaviors in the post-COVID-19 era in China. BMC Public Health. 21(1):1743 (2021). doi: 10.1186/s12889-021-11823-4. Retraction in: BMC Public Health. 2021 Dec 10;21(1):2244 [DOI] [PMC free article] [PubMed]
- Mao, K.: WITHDRAWN: Health risk assessment and health management of urban residents facing epidemic pneumonia. Work. (2021). doi: 10.3233/WOR-205367. Epub ahead of print. Retraction in: Work. 2021;70(2):673–674 [DOI] [PubMed]
- Mehra, M.R., Desai, S.S., Ruschitzka, F., Patel, A.N.: RETRACTED: Hydroxychloroquine or chloroquine with or without a macrolide for treatment of COVID-19: a multinational registry analysis. Lancet. 22:S0140–6736(20)31180–6 (2020a). doi: 10.1016/S0140-6736(20)31180-6. Epub ahead of print. Retraction in: Lancet. 2020a Jun 5;:null. Erratum in: Lancet. 2020a May 30
- Mehra MR, Desai SS, Kuy S, Henry TD, Patel AN. Cardiovascular Disease, Drug Therapy, and Mortality in Covid-19. N Engl J Med. 2020b Jun 18;382(25):e102. doi:10.1056/NEJMoa2007621. Epub 2020b May 1. Retraction in: N Engl J Med. 2020b Jun 4;: PMID: 32356626; PMCID: PMC7206931. [DOI] [PMC free article] [PubMed] [Retracted]
- Messina, F., Montaldo, C., Abbate, I., Antonioli, M., Bordoni, V., Matusali, G., Sacchi, A., Giombini, E., Fimia, G.M., Piacentini, M., Capobianchi, M.R., Lauria, F.N., Ippolito, G.: On behalf of covid-scoping review working group. rationale and criteria for a COVID-19 model framework. Viruses. 13(7):1309 (2021). doi: 10.3390/v13071309. Retraction in: Viruses. 2021 Jul 29;13(8) [DOI] [PMC free article] [PubMed] [Retracted]
- Moher, D., Liberati, A., Tetzlaff, J., Altman, D.G., PRISMA Group.: Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Ann. Intern. Med. Aug 18;151(4):264–9, W64 (2009) [DOI] [PubMed]
- Mulvey, J.J., Magro, C.M., Ma, L.X., Nuovo, G.J., Baergen, R.N.: WITHDRAWN: A mechanistic analysis placental intravascular thrombus formation in COVID-19 patients. Ann. Diagn. Pathol. 46:151529 (2020). doi: 10.1016/j.anndiagpath.2020.151529. Retraction in: Ann. Diagn. Pathol. 2020 Jun 22;:151550 [DOI] [PMC free article] [PubMed]
- Nagra, M.H., Ehsan, S., Ahmad, U., Ali, M., Hussain, H.A., Bakar, A.: Implementation of a telemedicine service during COVID-19 pandemic in Pakistan. Int J Clin Pract. 75(8):e14310 (2021). doi: 10.1111/ijcp.14310. Epub 2021 May 18. Retraction in: Int J Clin Pract. 2021 Dec;75(12):e14925. [DOI] [PMC free article] [PubMed] [Retracted]
- Palayew A, Norgaard O, Safreed-Harmon K, et al. Pandemic publishing poses a new COVID-19 challenge. Nat. Hum. Behav. 2020;4:666–669. doi: 10.1038/s41562-020-0911-0. [DOI] [PubMed] [Google Scholar]
- Paulus FM, Cruz N, Krach S. The Impact Factor Fallacy. Front Psychol. 2018;20(9):1487. doi: 10.3389/fpsyg.2018.01487. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Pawłowicz-Szlarska E, Sawościan M, Lipińska K, et al. Interprofessional collaboration in the renal care settings: experiences in the COVID-19 era. Adv. Clin. Exp. Med. Off. Organ Wroc. Med. Univ. 2022;31(7):749–755. doi: 10.17219/acem/146777. [DOI] [PubMed] [Google Scholar]
- Pian W, Chi J, Ma F. The causes, impacts and countermeasures of COVID-19 "infodemic": a systematic review using narrative synthesis. Inf. Process Manag. 2021 doi: 10.1016/j.ipm.2021.102713. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Saha, P., Mukherjee, D., Singh, P.K., Ahmadian, A., Ferrara, M., Sarkar, R.: GraphCovidNet: A graph neural network based model for detecting COVID-19 from CT scans and X-rays of chest. Sci Rep. 11(1):8304 (2021). doi: 10.1038/s41598-021-87523-1. Retraction in: Sci Rep. 2021 Nov 30;11(1):23451 [DOI] [PMC free article] [PubMed]
- Samaha, A.A., Mouawia, H., Fawaz, M., Hassan, H., Salami, A., Bazzal, A.A., Saab, H.B., Al-Wakeel, M., Alsaabi, A., Chouman, M., Moussawi, M.A., Ayoub, H., Raad, A., Hajjeh, O., Eid, A.H., Raad, H.: Effects of a single dose of ivermectin on viral and clinical outcomes in asymptomatic SARS-CoV-2 infected subjects: a pilot clinical trial in Lebanon. Viruses. 26;13(6):989 (2021). doi: 10.3390/v13060989. Retraction in: Viruses. 2021 Oct 26;13(11) [DOI] [PMC free article] [PubMed] [Retracted]
- Savaris, R.F., Pumi, G., Dalzochio, J., Kunst, R.: Stay-at-home policy is a case of exception fallacy: an internet-based ecological study. Sci Rep. 11(1):5313 (2021). doi: 10.1038/s41598-021-84092-1. Retraction in: Sci Rep. 2021 Dec 14;11(1):24172 [DOI] [PMC free article] [PubMed] [Retracted]
- Saxena, S.: Coronavirus disease-2019: a brief compilation of facts. J Oral Maxillofac Pathol. 24(1):5–7 (2020). doi: 10.4103/jomfp.JOMFP_137_20. Epub 2020 May 8. Retraction in: J Oral Maxillofac Pathol. 2020 May-Aug;24(2):407 [DOI] [PMC free article] [PubMed] [Retracted]
- Schonhaut L, Costa-Roldan I, Oppenheimer I, et al. Scientific publication speed and retractions of COVID-19 pandemic original articles. Revista Panamericana de Salud Publica Pan Am. J. Public Health. 2022 doi: 10.26633/RPSP.2022.25. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Singh, A.: Noninvasive versus invasive ventilation: one modality cannot fit all during COVID-19 outbreak. Korean J. Anesthesiol. 73(4):359–360 (2020). doi: 10.4097/kja.20227. Epub 2020 Jul 8. Retraction in: Korean J Anesthesiol. 2020 Oct;73(5):468 [DOI] [PMC free article] [PubMed]
- Standish, K.: COVID-19, suicide, and femicide: Rapid research using google search phrases. J Gen Psychol. 148(3):305–326 (2021). doi: 10.1080/00221309.2021.1874863. Epub 2021 Jan 22. Retraction in: J Gen Psychol. 2021 May 19;:1 [DOI] [PubMed]
- Sun, M., Guo, D., Zhang, J., Zhang, J., Teng, H.F., Xia, J., Liu, P., Ge, Q.X., Wang, M.Y.: Anal swab as a potentially optimal specimen for SARS-CoV-2 detection to evaluate hospital discharge of COVID-19 patients. Future Microbiol.15:1101–1107 (2020). doi: 10.2217/fmb-2020-0090. Epub 2020 Aug 14. Retraction in: Future Microbiol. 2021 May;16:537 [DOI] [PMC free article] [PubMed] [Retracted]
- Temmerman, M.: Family planning in COVID-19 times: access for all. Lancet Glob Health. 9(6):e728-e729 (2021). doi: 10.1016/S2214-109X(21)00231-X. Retraction in: Lancet Glob Health. 2021 Jun 25;:null [DOI] [PMC free article] [PubMed] [Retracted]
- The World Bank, World Bank Country and Lending Groups (2021), Retrieved from: https://datahelpdesk.worldbank.org/knowledgebase/articles/906519-world-bank-country-and-lending-groups
- Vainshelboim, B.: Retracted: facemasks in the COVID-19 era: a health hypothesis. Med. Hypotheses. 146:110411 (2021). doi: 10.1016/j.mehy.2020.110411. Epub 2020 Nov 22. Retraction in: Med Hypotheses. 2021 May 12;:110601 [DOI] [PMC free article] [PubMed]
- Victor, G.: COVID-19 admissions calculators - revisited. Early Hum. Dev.;144:105053 (2020a). doi: 10.1016/j.earlhumdev.2020a105053. Epub 2020a Apr 25. Retraction in: Early Hum Dev. 2021 Jun 23;159:105412 [DOI] [PMC free article] [PubMed]
- Victor, G.: COVID-19 admissions calculators: General population and paediatric cohort. Early Hum. Dev.;145:105043 (2020b). doi: 10.1016/j.earlhumdev.2020b105043. Epub 2020b Apr 10. Retraction in: Early Hum Dev. 2021 Jun 17;159:105410 [DOI] [PMC free article] [PubMed] [Retracted]
- Viswanathan, M., Berkman, N.D., Dryden, D.M., Hartling, L.: Assessing risk of bias and confounding in observational studies of interventions or exposures: further development of the RTI item bank [Internet]. Rockville (MD): Agency for Healthcare Research and Quality (US); 2013 Aug. Report No.: 13-EHC106-EF [PubMed]
- Vrabel M. Beyond the Impact Factor. Oncol Nurs Forum. 2019;46(2):143–145. doi: 10.1188/19.ONF.143-145. [DOI] [PubMed] [Google Scholar]
- Vuong QH, La VP, Ho MT, et al. Characteristics of retracted articles based on retraction data from online sources through February 2019. Sci Ed. 2020 doi: 10.6087/kcse.187. [DOI] [Google Scholar]
- Walach, H., Klement, R.J., Aukema, W.: Retracted: the safety of covid-19 vaccinations-we should rethink the policy. Vaccines (Basel). 24;9(7):693 (2021). doi: 10.3390/vaccines9070693. Retraction in: Vaccines (Basel). 2021 Jul 02;9(7):null [DOI] [PMC free article] [PubMed] [Retracted]
- Wang, X., Xu, W., Hu, G., Xia, S., Sun, Z., Liu, Z., Xie, Y., Zhang, R., Jiang, S., Lu, L.: RETRACTED ARTICLE: SARS-CoV-2 infects T lymphocytes through its spike protein-mediated membrane fusion. Cell. Mol. Immunol. 1–3 (2020). doi:10.1038/s41423-020-0424-9. Epub ahead of print. Retraction in: Cell Mol Immunol. 2020 Aug;17(8):894. [DOI] [PMC free article] [PubMed]
- Retraction watch, retracted coronavirus (COVID-19) papers, https://retractionwatch.com/retracted-coronavirus-covid-19-papers/. Accessed on 9 August 2022
- Watson C. Rise of the preprint: how rapid data sharing during COVID-19 has changed science forever. Nat. Med. 2022;28:2–5. doi: 10.1038/s41591-021-01654-6. [DOI] [PubMed] [Google Scholar]
- Woodle, E.S., Gebel, H.M., Montgomery, R.A., Maltzman, J.S.: SARS-CoV-2 vaccination and antibody testing in immunosuppressed populations: you can't tell the players without a scorecard [RETRACTED]. Transplantation. (2021). doi: 10.1097/TP.0000000000003882. Epub ahead of print. Retraction in: Transplantation. 2021 Sep 1;105(9):e113 [DOI] [PubMed]
- Yeo-Teh NSL, Tang BL. An alarming retraction rate for scientific publications on coronavirus disease COVID-19. Account. Res. 2019 doi: 10.1080/08989621.2020.1782203. [DOI] [PubMed] [Google Scholar]
- Zago Filho, L.A., Lima, L.H., Melo, G.B., Zett, C., Farah, M.E.: Vitritis and outer retinal abnormalities in a patient with COVID-19. Ocul. Immunol. Inflamm. 28(8):1298–1300 (2020). doi: 10.1080/09273948.2020.1821898. Epub 2020 Oct 6. Retraction in: Ocul Immunol Inflamm. 2021 Jul 4;29(5):1035 [DOI] [PubMed]
- Zaidi, A.K., Dehgani-Mobaraki, P.: The mechanisms of action of ivermectin against SARS-CoV-2-an extensive review. J. Antibiot. (Tokyo). 75(2):60–71 (2022). doi: 10.1038/s41429-021-00491-6. Epub 2021 Dec 21. Retraction in: J Antibiot (Tokyo). 2022 Feb;75(2):122. [DOI] [PMC free article] [PubMed]
- Zellmer, W.A.: How pharmacists can help heal democracy in America. Am J Health Syst Pharm. 78(6):525-526 (2021). doi: 10.1093/ajhp/zxaa435. Retraction in: Am. J. Health Syst Pharm. 2021 Jan 20;:null [DOI] [PMC free article] [PubMed] [Retracted]
- Zeng, Y., Zhen, Y.: Chinese medical staff request international medical assistance in fighting against COVID-19. Lancet Glob Health. S2214–109X(20)30065–6 (2020). doi: 10.1016/S2214-109X(20)30065-6. Epub ahead of print. Retraction in: Lancet Glob Health. 2020 Aug;8(8):e995
- Zhao, X., Liu, R., Miao, Z., Ye, N., Lu, W.: Retracted:a study of potential SARS-CoV-2 antiviral drugs and preliminary research of their molecular mechanism, based on Anti-SARS-CoV drug screening and molecular dynamics simulation. J. Comput. Biol. (2020). doi: 10.1089/cmb.2020.0112. Epub ahead of print. Retraction in: J Comput Biol. 2021 Jul;28(7):744. [DOI] [PubMed]